$Spero Therapeutics, Inc.(SPRO)$ 8-K - Current report Filed: 2017-12-14 AccNo: 0001193125-17-369517 Size: 68 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接